Chr. Hansen

EN Texto en inglés Aún no hay artículo en tu idioma: extracto en inglés.

Chr. Hansen A/S was a biotechnology company based in Hørsholm, Denmark. The company is a supplier of bacteria cultures, probiotics, enzymes and human milk oligosaccharides. Its products are used in the production of fresh dairy, cheese, meat, seafood, fermented beverages, dairy and meat alternatives, dietary supplements, infant formula, pharmaceuticals and agricultural products. In 2021, Chr. Hansen A/S was ranked 1st on FoodTalks' Top 30 Global Probiotic Food Ingredient Companies list. Chr. Hansen owns one of the world's largest commercial bacteria collections. The company merged with Novozymes to form Novonesis in January 2024. Chr. Hansen A/S has development centers in Denmark, the United States, France and Germany including research facilities in Denmark and France. A large percentage of the employees engage in research and development for the international food and pharmaceuticals industries. Chr. Hansen A/S has five main production sites: two in Denmark and Germany (Nienburg and Pohlheim) and one each in France (Arpajon) and the US (West Allis, WI) and an international presence in 30 countries. It was previously listed on Nasdaq OMX Copenhagen under the symbol "CHR".